Company Filing History:
1 out of 1,744 
1 out of 5,089 
1 out of 132 
Years Active: 2018
Title: Thiago Trovati Maciel: Innovator in Cancer Treatment
Introduction
Thiago Trovati Maciel is a notable inventor based in Paris, France. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on addressing drug-resistant cancers and improving patient outcomes.
Latest Patents
Thiago holds a patent for a composition that combines a DNA methylation inhibitor and a vitamin D receptor agonist. This invention is aimed at treating drug-resistant cancer and preventing tumor relapse. The patent outlines the use of these two components, either simultaneously or sequentially, to enhance the sensitivity of cancer patients to chemotherapeutic drugs.
Career Highlights
Throughout his career, Thiago has worked with prestigious institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. His experience in these organizations has allowed him to contribute to groundbreaking research in the medical field.
Collaborations
Thiago has collaborated with esteemed colleagues, including Ivan Cruz-Moura and Olivier Hermine. These partnerships have further enriched his research and development efforts in cancer treatment.
Conclusion
Thiago Trovati Maciel is a pioneering inventor whose work in cancer treatment showcases the potential of innovative therapies. His contributions are vital in the ongoing fight against drug-resistant cancers and improving patient care.